Application 204361
- Type
- ANDA
- Sponsor
- USV
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EPTIFIBATIDE | EPTIFIBATIDE | INJECTABLE;INJECTION | 2MG/ML | No | No |
| 002 | EPTIFIBATIDE | EPTIFIBATIDE | INJECTABLE;INJECTION | 75MG/100ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204361-001 | EPTIFIBATIDE | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | ||
| A204361-002 | EPTIFIBATIDE | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204361-001 | EPTIFIBATIDE | 2MG/ML | INJECTABLE / INJECTION | 2019-03-14 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204361-002 | EPTIFIBATIDE | 75MG/100ML | INJECTABLE / INJECTION | 2019-03-14 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-09-15 20:21 UTC | 2019-09 | A204361-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A204361-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A204361-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A204361-002 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eptifibatide | EPTIFIBATIDE | Slate Run Pharmaceuticals, LLC | da421d88-6c00-428a-82a6-b3b4f7a68b85 | 2026-02-09 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Slate Run Pharmaceuticals, LLC | 2ab98ecd-c578-4032-a3d5-ae14d58d86a7 | 2026-02-09 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | c488f1af-a82c-4360-8886-79520635561a | 2025-10-20 | Warnings | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Avenacy, LLC | c0781dae-3ef6-4cab-b084-01d2e45f3764 | 2024-08-15 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| eptifibatide | EPTIFIBATIDE | Sagent Pharmaceuticals | a0d18778-0194-461a-a4ea-b2fca5df57c3 | 2024-08-15 | Warnings, Adverse reactions | eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Baxter Healthcare Company | 5f46b76b-5c83-49b9-ada8-4ad5cf81a38c | 2024-05-29 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Meitheal Pharmaceuticals Inc. | 3e7e7cd3-8efa-4d91-a5ab-7fd78b0cc65e | 2024-05-14 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Eugia US LLC | 00ad7bbe-cadd-4647-b74b-adfc9f2b5e94 | 2024-01-04 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Mylan Institutional LLC | a7a89c59-22fb-41fd-b70a-ac2395717db1 | 2021-05-28 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |
| Eptifibatide | EPTIFIBATIDE | Mylan Institutional LLC | 88a37f9c-496b-4a6b-9665-4550abba04f1 | 2021-05-28 | Warnings, Adverse reactions | Eptifibatide EPTIFIBATIDE |